andy cohen glp 1 weight loss from 'micro-dose' of GLP-1 drug Andy Cohen candidly revealed he

For research use, neither compound requires compounding pharmacy involvement they can be sourced directly as research raw materials

Moreover, dihexa is being researched for its capacity to stimulate the repair of damaged brain cells

This lets you capture the benefits of GLP-1 agonism at lower cost

Single-compound peptide: PT-141 (Bremelanotide) 10mg

This stratified approach avoids the one-size-fits-all assumptions that have constrained past indication extension attempts and provides a clearer, evidence-led path to expanding GLP-1 use where it is biologically and clinically justified.

This led to clinical trials specifically for obesity, and several are now FDA-approved for weight management